Publicaciones en las que colabora con JOSE LUIS LLORENTE PENDAS (31)

2024

  1. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma

    Cells, Vol. 13, Núm. 1

  2. Experimental Models of Sinonasal Tumors for Preclinical Testing of Candidate Targeted Therapies

    Current Otorhinolaryngology Reports, Vol. 12, Núm. 1, pp. 1-10

  3. Next-generation sequencing reveals remarkable genetic stability in primary and corresponding recurrent intestinal-type sinonasal adenocarcinoma

    Head and Neck

2023

  1. Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  2. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas

    Journal of Personalized Medicine, Vol. 13, Núm. 10

2022

  1. Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors

    Biomedicines, Vol. 10, Núm. 9

  2. Loss of p16 expression is a risk factor for recurrence in sinonasal inverted papilloma*

    Rhinology, Vol. 60, Núm. 6, pp. 1-9

2021

  1. Aberrant signaling pathways in sinonasal intestinal-type adenocarcinoma

    Cancers, Vol. 13, Núm. 19

  2. Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. CD8+ tumour-infiltrating lymphocytes and tumour microenvironment immune types as biomarkers for immunotherapy in sinonasal intestinal-type adenocarcinoma

    Vaccines, Vol. 8, Núm. 2

  2. IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management

    American Journal of Surgical Pathology, Vol. 44, Núm. 3, pp. 396-405

2018

  1. Genetic profiling of poorly differentiated sinonasal tumours

    Scientific Reports, Vol. 8, Núm. 1

  2. Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes

    Head and Neck, Vol. 40, Núm. 2, pp. 259-273

  3. Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer

    Head and Neck, Vol. 40, Núm. 4, pp. 818-827

2017

  1. Ausencia de translocaciones cromosómicas y de expresión proteica de ALK en los adenocarcinomas nasosinusales

    Acta Otorrinolaringologica Espanola, Vol. 68, Núm. 1, pp. 9-14

2016

  1. Gene Methylation Profiling in Sinonasal Adenocarcinoma and Squamous Cell Carcinoma

    Otolaryngology - Head and Neck Surgery (United States), Vol. 155, Núm. 5, pp. 808-815

  2. Primary inverted papilloma of the middle ear with intracranial invasion

    Head and Neck, Vol. 38, Núm. 5, pp. E105-E107

  3. Recurrent DNA copy number alterations in intestinal-type sinonasal adenocarcinoma

    Rhinology, Vol. 54, Núm. 3, pp. 278-286

2015

  1. Current management of sinonasal undifferentiated carcinoma

    Rhinology, Vol. 53, Núm. 3, pp. 1-9

  2. Current management of sinonasal undifferentiated carcinoma

    Rhinology, Vol. 53, Núm. 3, pp. 212-220